Volumetric YC Application
Volumetric went through Y Combinator in the Winter 2020 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2020
- Industry
- HealthcareIndustrial Bio
- Team size
- 5
- Status
- Acquired
- Launched
- 2020
Founders
Jordan MillerCo-Founder and President
Bagrat GrigoryanCo-Founder, COO
What Volumetric does
About Us Volumetric is a recognized world leader in building living multicellular tissues, with a focus on replicating discrete functions of the human body for basic mechanistic biology, laboratory testing and screening, and drug development. Founded in 2018 by Bagrat Grigoryan and Jordan Miller as a spin-out from Rice University, the full potential of our work is to build whole human organ replacements for patients, made from their own cells. Our Technology and Approach We have invented a suite of breakthrough 3D bioprinting technologies, featured on the cover of Science, that can build human tissue with complex blood vessel networks. We are leveraging this technology in the short term to build patient-specific tissues for drug safety and efficacy testing. Patient cells are taken from a biopsy, added to our proprietary 3D printed tissues, and then drug compounds are injected through the blood vessel network to mimic actual drug delivery in humans. Our vision is that our technology will provide rigorous, reproducible, and predictive outcomes for patients, resulting in drastically improved outcomes for diseases like cancer. More broadly, we see the full potential of our mission as being able to produce functional tissue and organ replacements for diseased or damaged vital organs in the body such as the lung, liver, pancreas, kidney, and heart.
Volumetric's YC application, reconstructed
Y Combinator application
Volumetric, Winter 2020 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Volumetric
Build living multicellular human tissues
We build living human tissues with complex blood vessel networks using proprietary 3D bioprinting technology. Our product replicates discrete human organ functions for biology research, drug testing, and drug safety screening. We take patient cells from biopsies, add them to printed tissues, and deliver drugs through built-in vessels to mimic real human responses. Long term, we aim to replace diseased organs with functional, patient-specific tissues.
We are based in Houston, TX, and the company would remain there after YC.
Houston puts us close to Rice University where our technology started and provides access to biomedical and industrial bio partners. We're rooted here and it's where our team and ecosystem are strongest.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Volumetric YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Volumetric's public data (launch notes, founder backgrounds, product description). It shows how a company like Volumetric would present itself to YC, not the text they submitted.
What YC batch was Volumetric in?
Volumetric was part of the Y Combinator Winter 2020 batch.
Who founded Volumetric?
Volumetric was founded by Jordan Miller, Bagrat Grigoryan.
What does Volumetric do?
Volumetric builds living multicellular tissues with a focus on the…
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Volumetric's application, and every other YC batch, is in YC Insights.
More YC startups like Volumetric
